Hopkinton, MA, United States of America

Cheryl Murphy


Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 92(Granted Patents)


Company Filing History:


Years Active: 2001-2013

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Cheryl Murphy

Introduction

Cheryl Murphy, based in Hopkinton, MA, is a prolific inventor known for her significant contributions to the field of biotechnology. With a remarkable portfolio of six patents, Murphy has made strides in research related to granulocytic ehrlichia, showcasing her dedication to advancing medical science.

Latest Patents

Among her notable inventions are her latest patents that focus on the characterization of granulocytic ehrlichia. The first patent pertains to polypeptides containing antigenic epitopes from granulocytic ehrlichia (GE) proteins and outlines methods for their use, aiming to enhance understanding and treatment options for infections. The second patent centers on innovative methods for screening samples taken from subjects for antibodies related to granulocytic ehrlichia infection, providing vital tools for diagnosis and research.

Career Highlights

Cheryl has honed her expertise while working with esteemed organizations such as Antigenics, Inc. and Aquila Biopharmaceuticals Inc. Her experiences in these companies provided her with in-depth knowledge and practical skills that have contributed to her innovative work.

Collaborations

Throughout her career, Cheryl has collaborated with notable colleagues, including James Storey and Gerald A Beltz. These partnerships have further enriched her research endeavors and have helped in propagating essential findings in her field.

Conclusion

Cheryl Murphy stands out as an influential inventor whose work on granulocytic ehrlichia has the potential to impact diagnostics and treatment significantly. Her dedication and innovative spirit continue to inspire future discoveries in the realm of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…